InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,658.00
(
0.32%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.27
(
0.38%
)
Bitcoin
62,758.41
(
-0.46%
)
Post# of 15274
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

powderbum

Send PM Follow Ignore
Followers 11
Posts 2159
Boards Moderated 0
Alias Born 04/22/2009

powderbum

Re: None

Sunday, 01/11/2015 5:21:59 PM

Sunday, January 11, 2015 5:21:59 PM

Post# of 15274
Looks like Johns Hopkins is ready to start their RANDOMIZED, DOUBLE BLIND CALMARE CIPN study.

https://www.clinicaltrials.gov/ct2/show/NCT02111174?term=calmare&rank=1

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Outcomes Assessor)
Primary Purpose: Supportive Care

Estimated Enrollment: 30
Study Start Date:January 2015
Estimated Study Completion Date: January 2017
Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up